113 related articles for article (PubMed ID: 20028961)
1. Evaluation of a pharmacist-managed telephone lipid clinic at a Veterans Affairs Medical Center.
Fabbio KL; Bradley M; Chrymko M
Ann Pharmacother; 2010 Jan; 44(1):50-6. PubMed ID: 20028961
[TBL] [Abstract][Full Text] [Related]
2. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of a pharmacy care management program for veterans with dyslipidemia.
Smith MC; Boldt AS; Walston CM; Zillich AJ
Pharmacotherapy; 2013 Jul; 33(7):736-43. PubMed ID: 23625745
[TBL] [Abstract][Full Text] [Related]
4. Lipid levels and use of lipid-lowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA Medical Centers.
Mazzolini TA; Irons BK; Schell EC; Seifert CF
J Manag Care Pharm; 2005; 11(9):763-71. PubMed ID: 16300420
[TBL] [Abstract][Full Text] [Related]
5. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS
Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of a pharmacist-physician co-managed programme on hyperlipidaemia management in Hong Kong.
Lee VW; Fan CS; Li AW; Chau AC
J Clin Pharm Ther; 2009 Aug; 34(4):407-14. PubMed ID: 19583673
[TBL] [Abstract][Full Text] [Related]
7. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
Cooke CE; Hammerash WJ
Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470
[TBL] [Abstract][Full Text] [Related]
8. Switching statin therapy using a pharmacist-managed therapeutic conversion program versus usual care conversion among indigent patients.
Miller AE; Hansen LB; Saseen JJ
Pharmacotherapy; 2008 May; 28(5):553-61. PubMed ID: 18447653
[TBL] [Abstract][Full Text] [Related]
9. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center.
Collins C; Kramer A; O'Day ME; Low MB
Am J Health Syst Pharm; 2006 Sep; 63(18):1723-7. PubMed ID: 16960256
[TBL] [Abstract][Full Text] [Related]
11. Impact of obtaining medications from pharmaceutical company assistance programs on therapeutic goals.
Trompeter JM; Havrda DE
Ann Pharmacother; 2009 Mar; 43(3):469-77. PubMed ID: 19240259
[TBL] [Abstract][Full Text] [Related]
12. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
Sarawate CA; Cziraky MJ; Stanek EJ; Willey VJ; Corbelli JC; Charland SL
Clin Ther; 2007 Jan; 29(1):196-209. PubMed ID: 17379061
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
14. Baseline achievement of lipid goals and usage of lipid medications in patients with diabetes mellitus (from the Veterans Affairs Diabetes Trial).
Meyers CD; McCarren M; Wong ND; Abraira C; Duckworth WC; Kashyap ML;
Am J Cardiol; 2006 Jul; 98(1):63-5. PubMed ID: 16784922
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a pharmacist-managed lipid clinic: in-person versus telephone.
Dolder NM; Dolder CR
J Am Pharm Assoc (2003); 2010; 50(3):375-8. PubMed ID: 20452911
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study.
Koren MJ; Hunninghake DB;
J Am Coll Cardiol; 2004 Nov; 44(9):1772-9. PubMed ID: 15519006
[TBL] [Abstract][Full Text] [Related]
18. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of a fenofibrate 145-mg nanoparticle tablet formulation compared with the standard 160-mg tablet in patients with coronary heart disease and dyslipidemia.
Maciejewski S; Hilleman D
Pharmacotherapy; 2008 May; 28(5):570-5. PubMed ID: 18447655
[TBL] [Abstract][Full Text] [Related]
20. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]